Efficacy and safety of oral sarecycline for the treatment of moderate to severe facial acne vulgaris: Results of a phase 2, dose-ranging trial

Category Primary study
JournalJournal of the American Academy of Dermatology
Year 2017
This article has no abstract
Epistemonikos ID: d0d6189324f9fec0c4011cb5b813c0be326e3da9
First added on: Feb 08, 2025